NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $211,573 | -17.9% | 3,518 | +0.1% | 0.03% | -22.2% |
| Q4 2022 | $257,679 | -3.5% | 3,513 | -0.2% | 0.04% | -16.3% |
| Q3 2022 | $267,000 | +9.4% | 3,520 | +0.1% | 0.04% | +16.2% |
| Q2 2022 | $244,000 | -16.2% | 3,516 | +0.2% | 0.04% | -5.1% |
| Q1 2022 | $291,000 | +10.6% | 3,509 | 0.0% | 0.04% | +11.4% |
| Q4 2021 | $263,000 | -36.2% | 3,509 | +0.1% | 0.04% | -37.5% |
| Q3 2021 | $412,000 | -47.0% | 3,507 | 0.0% | 0.06% | -47.7% |
| Q2 2021 | $778,000 | +67.7% | 3,507 | 0.0% | 0.11% | +55.1% |
| Q1 2021 | $464,000 | -23.6% | 3,507 | 0.0% | 0.07% | -34.3% |
| Q4 2020 | $607,000 | – | 3,507 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |